Radoul, M., Chaumeil, M. M., Eriksson, P., Wang, A. S., Phillips, J. J., & Ronen, S. M. (2016). MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide – Metabolic Changes are Associated with Enhanced Survival. Mol Cancer Ther.

Radoul, Marina, Myriam M. Chaumeil, Pia Eriksson, Alan S. Wang, Joanna J. Phillips, and Sabrina M. Ronen. "MR Studies of Glioblastoma Models Treated With Dual PI3K/mTOR Inhibitor and Temozolomide – Metabolic Changes Are Associated With Enhanced Survival." Mol Cancer Ther 2016.

Radoul, Marina, et al. "MR Studies of Glioblastoma Models Treated With Dual PI3K/mTOR Inhibitor and Temozolomide – Metabolic Changes Are Associated With Enhanced Survival." Mol Cancer Ther 2016.